Status and further development of "ambulante spezialfachärztliche Versorgung" ("outpatient specialist medical care"; ASV) in urologic cancer diseases

Status and further development of "ambulante spezialfachärztliche Versorgung" ("outpatient specialist medical care"; ASV) in urologic cancer diseases - ASV-WE

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00025403

Enrollment

1800

Registered

2021-08-02

Start date

2022-01-03

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C61

Interventions

Group 1: group of interest: anonymous survey of about 900 patients with advanced or metastastic prostate cancer (about 60 patients per ASV practice/clinic) Group 2: control: anonymous survey of about

Eligibility

Sex/Gender

Male

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: patients with advanced or metastatic prostate cancer

Exclusion criteria

Exclusion criteria: patients with no advanced or metastatic prostate cancer

Design outcomes

Primary

Measure	Time frame
The study aims to explore and evaluate ASV goals in urological cancer diseases.	—

Secondary

Measure	Time frame
Secondary endpoints include amongst patients' satisfaction, access to treatment, coordination of treatment and quality of life.	—

Countries

Germany

Contacts

Public ContactAmanda Breckner

Abt. Allgemeinmedizin und Versorgungsforschung Universitätsklinikum Heidelberg

Amanda.breckner@med.uni-heidelberg.de+49 6221 56-34646

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026